Skip to main content
NYSE:CVII

Churchill Capital Corp VII Competitors

$9.77
0.00 (0.00 %)
(As of 05/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.76
$9.78
50-Day Range N/A
52-Week Range
$9.75
$10.00
Volume105,537 shs
Average Volume326,375 shs
Market Capitalization$381.91 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Churchill Capital Corp VII (NYSE:CVII) Vs. AJAX, AJAX, PNTM, VSPR, BOWX, and BTWN

Should you be buying CVII stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Churchill Capital Corp VII, including Ajax I (AJAX), Ajax I (AJAX), Pontem (PNTM), Vesper Healthcare Acquisition (VSPR), BowX Acquisition (BOWX), and Bridgetown (BTWN).

Churchill Capital Corp VII (NYSE:CVII) and Ajax I (NYSE:AJAX) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Churchill Capital Corp VII and Ajax I, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Churchill Capital Corp VII0000N/A
Ajax I0000N/A

Profitability

This table compares Churchill Capital Corp VII and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Churchill Capital Corp VIIN/AN/AN/A
Ajax IN/AN/AN/A

Earnings and Valuation

This table compares Churchill Capital Corp VII and Ajax I's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Churchill Capital Corp VIIN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Churchill Capital Corp VII (NYSE:CVII) and Ajax I (NYSE:AJAX) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Churchill Capital Corp VII and Ajax I, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Churchill Capital Corp VII0000N/A
Ajax I0000N/A

Profitability

This table compares Churchill Capital Corp VII and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Churchill Capital Corp VIIN/AN/AN/A
Ajax IN/AN/AN/A

Earnings and Valuation

This table compares Churchill Capital Corp VII and Ajax I's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Churchill Capital Corp VIIN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Churchill Capital Corp VII (NYSE:CVII) and Pontem (NYSE:PNTM) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Churchill Capital Corp VII and Pontem, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Churchill Capital Corp VII0000N/A
Pontem0000N/A

Profitability

This table compares Churchill Capital Corp VII and Pontem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Churchill Capital Corp VIIN/AN/AN/A
PontemN/AN/AN/A

Earnings and Valuation

This table compares Churchill Capital Corp VII and Pontem's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Churchill Capital Corp VIIN/AN/AN/AN/AN/A
PontemN/AN/AN/AN/AN/A

Churchill Capital Corp VII (NYSE:CVII) and Vesper Healthcare Acquisition (NASDAQ:VSPR) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Churchill Capital Corp VII and Vesper Healthcare Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Churchill Capital Corp VII0000N/A
Vesper Healthcare Acquisition00203.00

Vesper Healthcare Acquisition has a consensus price target of $15.75, suggesting a potential upside of 12.02%. Given Vesper Healthcare Acquisition's higher possible upside, analysts plainly believe Vesper Healthcare Acquisition is more favorable than Churchill Capital Corp VII.

Profitability

This table compares Churchill Capital Corp VII and Vesper Healthcare Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Churchill Capital Corp VIIN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/A

Earnings and Valuation

This table compares Churchill Capital Corp VII and Vesper Healthcare Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Churchill Capital Corp VIIN/AN/AN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/AN/AN/A

Summary

Vesper Healthcare Acquisition beats Churchill Capital Corp VII on 2 of the 2 factors compared between the two stocks.

Churchill Capital Corp VII (NYSE:CVII) and BowX Acquisition (NASDAQ:BOWX) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Churchill Capital Corp VII and BowX Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Churchill Capital Corp VII0000N/A
BowX Acquisition0000N/A

Profitability

This table compares Churchill Capital Corp VII and BowX Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Churchill Capital Corp VIIN/AN/AN/A
BowX AcquisitionN/AN/AN/A

Earnings and Valuation

This table compares Churchill Capital Corp VII and BowX Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Churchill Capital Corp VIIN/AN/AN/AN/AN/A
BowX AcquisitionN/AN/AN/AN/AN/A

Churchill Capital Corp VII (NYSE:CVII) and Bridgetown (NASDAQ:BTWN) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Churchill Capital Corp VII and Bridgetown, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Churchill Capital Corp VII0000N/A
Bridgetown0000N/A

Earnings and Valuation

This table compares Churchill Capital Corp VII and Bridgetown's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Churchill Capital Corp VIIN/AN/AN/AN/AN/A
BridgetownN/AN/AN/AN/AN/A

Profitability

This table compares Churchill Capital Corp VII and Bridgetown's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Churchill Capital Corp VIIN/AN/AN/A
BridgetownN/AN/AN/A


Churchill Capital Corp VII Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$9.94flat$889.06 millionN/A0.00
Ajax I logo
AJAX
Ajax I
0.0$9.94flat$889.06 millionN/A0.00
PNTM
Pontem
0.0$9.74flat$840.08 millionN/A0.00
Vesper Healthcare Acquisition logo
VSPR
Vesper Healthcare Acquisition
1.5$14.06flat$808.45 millionN/A0.00
BOWX
BowX Acquisition
0.0$12.50flat$754.69 millionN/A0.00
BTWN
Bridgetown
0.0$10.10flat$751.18 millionN/A0.00
BOAC
Bluescape Opportunities Acquisition
0.0$9.85flat$747.99 millionN/A0.00
VYGG
Vy Global Growth
0.0$10.03flat$720.91 millionN/A0.00
LGAC
Lazard Growth Acquisition Corp. I
0.0$9.84flat$707.25 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.92flat$702.98 millionN/A0.00Analyst Revision
HZON
Horizon Acquisition Co. II
0.0$10.03flat$664.93 millionN/A0.00
ASZ
Austerlitz Acquisition Co. II
0.0$9.78flat$629.32 millionN/A0.00
ACIC
Atlas Crest Investment
0.0$9.88flat$617.50 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.3$14.03flat$613.81 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.69flat$605.63 millionN/A0.00
CMLF
CM Life Sciences
0.0$10.90flat$603.25 millionN/A0.00
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.25flat$576.56 millionN/A0.00
VAQC
Vector Acquisition Co. II
0.0$9.93flat$569.49 millionN/A0.00News Coverage
KVSC
Khosla Ventures Acquisition Co. III
0.0$9.98flat$561.87 millionN/A0.00
HAAC
Health Assurance Acquisition
0.0$10.05flat$556.52 millionN/A0.00
GSEV
Gores Holdings VII
0.0$9.85flat$555.34 millionN/A0.00
MUDS
Mudrick Capital Acquisition Co. II
0.0$13.41flat$530.11 millionN/A0.00News Coverage
MAAC
Montes Archimedes Acquisition
0.0$9.87flat$518.89 millionN/A0.00
NGAB
Northern Genesis Acquisition Corp. II
0.0$9.81flat$507.67 millionN/A0.00
MOTV
Motive Capital
0.0$9.76flat$505.08 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.76flat$505.08 millionN/A0.00
DGNU
Dragoneer Growth Opportunities Corp. III
0.0$10.00flat$500 millionN/A0.00News Coverage
Supernova Partners Acquisition logo
SPNV
Supernova Partners Acquisition
0.0$9.89flat$497.60 millionN/A0.00
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.70flat$496.77 millionN/A0.00
NSTD
Northern Star Investment Corp. IV
0.0$9.93flat$496.50 millionN/A0.00Gap Up
EPHY
Epiphany Technology Acquisition
0.0$9.70flat$495.79 millionN/A0.00
GMII
Gores Metropoulos II
0.0$9.89flat$494.50 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.76flat$491.06 millionN/A0.00
SRNG
Soaring Eagle Acquisition
0.0$9.89flat$489.43 millionN/A0.00
DCRN
Decarbonization Plus Acquisition Co. II
0.0$9.67flat$486.53 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.0$10.31flat$463.95 millionN/A0.00
NGAC
NextGen Acquisition
0.0$9.88flat$463.13 millionN/A0.00News Coverage
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.00flat$461 millionN/A0.00
HIGA
H.I.G. Acquisition
0.0$9.79flat$445.38 millionN/A0.00
LUXA
Lux Health Tech Acquisition
0.0$10.01flat$431.68 millionN/A0.00
SPFR
Jaws Spitfire Acquisition
0.0$9.91flat$427.37 millionN/A0.00
CAP
Capitol Investment Corp. V
0.0$9.90flat$426.94 millionN/A0.00
RMGB
RMG Acquisition Co. II
0.0$9.86flat$425.21 millionN/A0.00News Coverage
DHHC
DiamondHead
0.0$9.75flat$420.47 millionN/A0.00
ACII
Atlas Crest Investment Corp. II
0.0$9.73flat$419.39 millionN/A0.00
KURI
Alkuri Global Acquisition
0.0$9.72flat$419.18 millionN/A0.00
GFX
Golden Falcon Acquisition
0.0$9.67flat$417.02 millionN/A0.00
CBAH
CBRE Acquisition
0.0$9.77flat$412.91 millionN/A0.00High Trading Volume
PCPC
Periphas Capital Partnering
0.0$24.50flat$411.75 millionN/A0.00
NSTB
Northern Star Investment Corp. II
0.0$9.91flat$396.40 millionN/A0.00
This page was last updated on 5/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.